Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region

被引:59
作者
Hasenöhrl, RU
Jentjens, O
Silva, MAD
Tomaz, C
Huston, JP
机构
[1] Univ Dusseldorf, Inst Physiol Psychol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Ctr Biol & Med Res, D-40225 Dusseldorf, Germany
[3] Univ Sao Paulo, Dept Psychobiol, BR-14049 Ribeirao Preto, Brazil
关键词
neurokinin; basal forebrain; anxiolytic; anxiogenic; elevated plus-maze; social interaction;
D O I
10.1016/S0014-2999(98)00441-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is evidence that the neurokinin substance P plays a role in neural mechanisms governing learning and reinforcement. Reinforcing and memory-promoting effects of substance P were found after it was injected into several parts of the brain and intraperitoneally. With regard to the close Link between anxiety and memory processes for negative reinforcement learning, the aim of the present study was to gauge the effect of substance P on anxiety-related behaviors in the rat elevated plus-maze and social interaction test. Substance P was tested at injection sites where the neurokinin has been shown to promote learning and to serve as a reinforcer, namely in the periphery (after i.p. administration) and after injection into the nucleus basalis magnocellularis region. When administered i.p., substance P had a biphasic dose-response effect on behavior in the plus-maze with an anxiolytic-like action at 50 mu g/kg and an anxiogenic-like one at 500 mu g/kg. After unilateral microinjection into the nucleus basalis magnocellularis region, substance P (1 ng) was found to exert anxiolytic-like effects, because substance P-treated rats spent more time on the open arms of the plus-maze and showed an increase in time spent in social interaction. Furthermore, the anxiolytic effects of intrabasalis substance P were sequence-specific since injection of a compound with the inverse amino acid sequence of substance P (0.1 to 100 ng) did not influence anxiety parameters. These results show that substance P has anxiolytic-like properties in addition to its known promnestic and reinforcing effects, supporting the hypothesis of a close relationship between anxiety, memory and reinforcement processes. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:123 / 133
页数:11
相关论文
共 54 条
[1]   Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test [J].
Aguiar, MS ;
Brandao, ML .
PHYSIOLOGY & BEHAVIOR, 1996, 60 (04) :1183-1186
[2]   SUBSTANCE-P IN CSF OF PATIENTS WITH CHRONIC PAIN SYNDROMES [J].
ALMAY, BGL ;
JOHANSSON, F ;
VONKNORRING, L ;
LEGREVES, P ;
TERENIUS, L .
PAIN, 1988, 33 (01) :3-9
[3]   PEPTIDES AND THE BLOOD-BRAIN-BARRIER - LIPOPHILICITY AS A PREDICTOR OF PERMEABILITY [J].
BANKS, WA ;
KASTIN, AJ .
BRAIN RESEARCH BULLETIN, 1985, 15 (03) :287-292
[4]   PREPROTACHYKININ GENE-EXPRESSION IN THE FOREBRAIN - REGULATION BY DOPAMINE [J].
BANNON, MJ ;
HAVERSTICK, DM ;
SHIBATA, K ;
POOSCH, MS .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 632 :31-37
[5]   The cardiovascular startle response: Anxiety and the benzodiazepine receptor complex [J].
Berntson, GG ;
Hart, S ;
Sarter, M .
PSYCHOPHYSIOLOGY, 1997, 34 (03) :348-357
[6]   LINK BETWEEN EMOTIONAL MEMORY AND ANXIETY-STATES - A STUDY BY PRINCIPAL COMPONENT ANALYSIS [J].
BEUZEN, A ;
BELZUNG, C .
PHYSIOLOGY & BEHAVIOR, 1995, 58 (01) :111-118
[7]   RELATIONSHIP BETWEEN DOPAMINE RELEASE IN NUCLEUS-ACCUMBENS AND PLACE PREFERENCE INDUCED BY SUBSTANCE-P INJECTED INTO THE NUCLEUS BASALIS MAGNOCELLULARIS REGION [J].
BOIX, F ;
SANDOR, P ;
NOGUEIRA, PJC ;
HUSTON, JP ;
SCHWARTING, RKW .
NEUROSCIENCE, 1995, 64 (04) :1045-1055
[8]   ETHOPHARMACOLOGICAL ANALYSIS OF RAT BEHAVIOR ON THE ELEVATED PLUS-MAZE [J].
CRUZ, APM ;
FREI, F ;
GRAEFF, FG .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 49 (01) :171-176
[9]   EVIDENCE THAT THE ANXIOLYTIC-LIKE EFFECTS OF CHLORDIAZEPOXIDE ON THE ELEVATED PLUS-MAZE ARE CONFOUNDED BY INCREASES IN LOCOMOTOR-ACTIVITY [J].
DAWSON, GR ;
CRAWFORD, SP ;
COLLINSON, N ;
IVERSEN, SD ;
TRICKLEBANK, MD .
PSYCHOPHARMACOLOGY, 1995, 118 (03) :316-323
[10]  
De Lima T. C. M., 1997, Society for Neuroscience Abstracts, V23, P1859